Literature DB >> 14711824

Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by beta-arrestins 1 and 2.

Seungkirl Ahn1, Huijun Wei, Tiffany Runyan Garrison, Robert J Lefkowitz.   

Abstract

beta-Arrestin2 not only plays essential roles in seven membrane-spanning receptor desensitization and internalization but also functions as a signal transducer in mitogen-activated protein kinase cascades. Here we show that the angiotensin II type 1A receptor-mediated activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) in HEK-293 cells is increased when the cellular level of beta-arrestin1 is down-regulated by RNA interference but is decreased or eliminated when the cellular level of beta-arrestin2 is diminished. Such reciprocal effects of down-regulated levels of beta-arrestins 1 and 2 are primarily due to differences in the ability of the two forms of beta-arrestins to directly mediate ERK activation. These results are the first to demonstrate reciprocal activity of beta-arrestin isoforms on a signaling pathway and suggest that physiological levels of beta-arrestin1 may act as "dominant-negative" inhibitors of beta-arrestin2-mediated ERK activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14711824     DOI: 10.1074/jbc.C300443200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  82 in total

1.  Receptor activity-independent recruitment of betaarrestin2 reveals specific signalling modes.

Authors:  Sonia Terrillon; Michel Bouvier
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

Review 2.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

3.  Activated human hydroxy-carboxylic acid receptor-3 signals to MAP kinase cascades via the PLC-dependent PKC and MMP-mediated EGFR pathways.

Authors:  Q Zhou; G Li; X Y Deng; X B He; L J Chen; C Wu; Y Shi; K P Wu; L J Mei; J X Lu; N M Zhou
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

Review 4.  Composition and function of g protein-coupled receptor signalsomes controlling mitogen-activated protein kinase activity.

Authors:  Louis M Luttrell
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 5.  Regulation of CXCR4 signaling.

Authors:  John M Busillo; Jeffrey L Benovic
Journal:  Biochim Biophys Acta       Date:  2006-11-10

6.  Altered expression and subcellular distribution of GRK subtypes in the dopamine-depleted rat basal ganglia is not normalized by l-DOPA treatment.

Authors:  M Rafiuddin Ahmed; Evgeny Bychkov; Vsevolod V Gurevich; Jeffrey L Benovic; Eugenia V Gurevich
Journal:  J Neurochem       Date:  2007-11-07       Impact factor: 5.372

7.  Beta-arrestin-mediated signaling regulates protein synthesis.

Authors:  Scott M DeWire; Jihee Kim; Erin J Whalen; Seungkirl Ahn; Minyong Chen; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2008-02-14       Impact factor: 5.157

Review 8.  Reviews in molecular biology and biotechnology: transmembrane signaling by G protein-coupled receptors.

Authors:  Louis M Luttrell
Journal:  Mol Biotechnol       Date:  2008-02-01       Impact factor: 2.695

9.  Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection.

Authors:  Takahisa Noma; Anthony Lemaire; Sathyamangla V Naga Prasad; Liza Barki-Harrington; Douglas G Tilley; Juhsien Chen; Philippe Le Corvoisier; Jonathan D Violin; Huijun Wei; Robert J Lefkowitz; Howard A Rockman
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

10.  β-Arrestin-2 deficiency attenuates abdominal aortic aneurysm formation in mice.

Authors:  Darshini B Trivedi; Charles D Loftin; James Clark; Page Myers; Laura M DeGraff; Jennifer Cheng; Darryl C Zeldin; Robert Langenbach
Journal:  Circ Res       Date:  2013-03-22       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.